Robert Way AI search startup Perplexity plans to pursue an initial public offering in 2028 regardless of how the market responds to the expected public listings of rivals OpenAI ( OPENAI ) and Anthropic ( ANTHRO ) , CNBC reported, citing an interview with CEO Aravind Srinivas . “Agnostic of these two companies, we were planning for something in 2028 so that remains the case,” Srinivas told CNBC . ...
Robert Way AI search startup Perplexity plans to pursue an initial public offering in 2028 regardless of how the market responds to the expected public listings of rivals OpenAI ( OPENAI ) and Anthropic ( ANTHRO ) , CNBC reported, citing an interview with CEO Aravind Srinivas . “Agnostic of these two companies, we were planning for something in 2028 so that remains the case,” Srinivas told CNBC . The comments come as the AI industry braces for a wave of high-profile listings. Srinivas had previously said Perplexity did not expect to go public before 2028 and his latest remarks provide a firmer target of a 2028 IPO. “I certainly think there will be ripple effects if they don’t go well, like there is no sugar coating on that. The SpaceX IPO this week will definitely be a leading indicator of how Anthropic or OpenAI will go out,” he added. “I think it’s important for the AI industry that these IPOs go well, and I actually think they will go well, because they’re doing well.” The lofty valuations of Anthropic ( ANTHRO ) and OpenAI ( OPENAI ), two of the world's leading AI "frontier labs," have drawn close attention from investors. Srinivas added that both companies merit premium valuations because they remain at the cutting edge of AI development. "If for six months you don't see a model capability advance from one of these two companies, then it's a problem for them," Srinivas said, adding that there are currently no signs of such a slowdown. Srinivas said a recent trend, dubbed "tokenmaxxing," has seen employees boost AI usage to signal productivity. “If there is an open source model that gets the job done 90% of the time, I’d probably use that if it’s 10 to 20 times cheaper than the frontier model,” Srinivas explained. “The future is still awesome for frontier intelligence, but it’s not going to be mindless spending, as we saw in the last few months.” More on goeasy: Vital Quarters Ahead Of Us, A Detailed Analysis PPC Ltd (PPCLY) Q4 2026 Earnings Call Transcript Blac...
About 3,000 residents at a Tsuen Wan housing estate have been left without water and with disrupted lift services for more than 24 hours after a power outage, with electricity only gradually restored around noon on Tuesday. The outage struck Phase 1 of Tsuen Wan Centre on Monday morning, affecting around 1,000 households across five blocks and a care home for people with disabilities. According to...
About 3,000 residents at a Tsuen Wan housing estate have been left without water and with disrupted lift services for more than 24 hours after a power outage, with electricity only gradually restored around noon on Tuesday. The outage struck Phase 1 of Tsuen Wan Centre on Monday morning, affecting around 1,000 households across five blocks and a care home for people with disabilities. According to a notice issued by the Tsuen Wan Centre Management Services Office on Tuesday morning, electricity...
JHVEPhoto/iStock Editorial via Getty Images goeasy Ltd. ( GSY:CA ) has had a tricky couple of months, and there could be further pain down the road. What started as concerns over its loan portfolio towards the end of 2025 quickly turned into an explosion in its LendCare portfolio, high delinquencies, high net charge-offs, and a revolving door of executives. With that being said, I believe goeasy, ...
JHVEPhoto/iStock Editorial via Getty Images goeasy Ltd. ( GSY:CA ) has had a tricky couple of months, and there could be further pain down the road. What started as concerns over its loan portfolio towards the end of 2025 quickly turned into an explosion in its LendCare portfolio, high delinquencies, high net charge-offs, and a revolving door of executives. With that being said, I believe goeasy, at these prices, could in theory be a buy, but I will rate it a short-term hold until I see clear execution and risks around charge-offs and LendCare decrease. The future of goeasy and the potential "buy" signal that may come will revolve around their 6-point Turnaround strategy. I want to make one thing clear to readers: I am planning to be risk averse with goeasy. I do not mind lower gains to reduce risk in a scenario such as this one, and this is why I am rating goeasy as a hold until I see what happens after Q2 2026 earnings and the July 1st audit results. With that being said, there are things I would like to see from goeasy not repeated in the future, even if the 6-point strategy is executed well. The Business goeasy is a Canadian subprime lender that provides loans to customers with a credit score in the sub-700s. As a subprime lender, the loans they provide are high in interest rate, around 25-35% APR for the most part, 35% being a hard cap due to regulation brought by the Canadian government in 2025. I disagree that this regulation helps the consumer since it encourages off-the- record, loan shark-type activity, but that is a discussion for another day. goeasy operates 3 main branches under their umbrella, all within the Canadian financial sector. easyfinancial, easyhome, and LendCare. easyfinancial offers direct secured and unsecured personal loans to goeasy customers. The loans are installment loans, and the amortization can range from 1 to 7 years. easyfinancial, together with LendCare (which will now become a single reporting entity), is almost the entire busin...
Wirestock GSK ( GSK ) is in talks to acquire oncology biotech Nuvalent ( NUVL ) for more than $9B, in what would be the British drugmaker’s largest acquisition in more than a decade, the Financial Times reported Tuesday. The companies have been in discussions with the aim of finalizing a deal as early as this week, the FT reported, citing people familiar with the matter. Both sides have yet to rea...
Wirestock GSK ( GSK ) is in talks to acquire oncology biotech Nuvalent ( NUVL ) for more than $9B, in what would be the British drugmaker’s largest acquisition in more than a decade, the Financial Times reported Tuesday. The companies have been in discussions with the aim of finalizing a deal as early as this week, the FT reported, citing people familiar with the matter. Both sides have yet to reach a final agreement, and the talks could still fall apart over last-minute hurdles, according to the report. A potential deal could value Nuvalent at between $9B and $10B, representing a premium of roughly 29% to 43% over the biotech company’s market capitalization of nearly $7B at Monday’s close. The deal would be the second largest acquisition in GSK’s history, the FT reported, trailing its 2014 asset swap with Novartis ( NVS ) in which it assumed control of the Swiss drugmaker’s vaccines division in a transaction valued at $20B. More on GSK, Nuvalent GSK plc (GSK) Presents at Jefferies Global Healthcare Conference 2026 Transcript GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment - Slideshow Three studies used to justify U.S. vaccine policy under RFK Jr. face scrutiny: Guardian GSK, Ionis mark late-stage trial win for chronic hepatitis B therapy
Ciena Corporation ( CIEN ) has announced the pricing of an upsized private offering of $2.5B in aggregate principal amount of 0.00% convertible senior notes due 2031. The deal size was increased from the previously signaled $2B. The offering is expected to close on June 11, 2026, subject to customary conditions. Ciena has also granted initial buyers a 13-day option to purchase up to an additional ...
Ciena Corporation ( CIEN ) has announced the pricing of an upsized private offering of $2.5B in aggregate principal amount of 0.00% convertible senior notes due 2031. The deal size was increased from the previously signaled $2B. The offering is expected to close on June 11, 2026, subject to customary conditions. Ciena has also granted initial buyers a 13-day option to purchase up to an additional $375M in notes. The senior unsecured notes carry a 0.00% coupon rate (no regular interest) and will mature on September 15, 2031, unless earlier converted, redeemed, or repurchased. The initial conversion rate is set at 1.3393 shares per $1,000 principal amount of notes. This equates to an initial conversion price of approximately $746.66 per share, representing a 60% conversion premium over Ciena's last reported sale price of $466.67 on June 8, 2026. Upon conversion, Ciena will pay cash up to the aggregate principal amount. For any remaining conversion obligation above that, the company retains the flexibility to settle in cash, common stock, or a combination of both. Ciena cannot redeem the notes prior to September 20, 2029, except under a "cleanup redemption" clause if outstanding notes fall below 10% of the initial principal volume. Ciena plans to use the net capital generated across several specific channels: $1.14B to repay outstanding amounts, associated fees, and expenses under its existing senior credit facility term loan. $140M to fund the concurrent repurchase of roughly 0.3M shares of common stock at a cost of $466.67 per share. $100M to cover the net cost of concurrent convertible note hedge and warrant transactions (the warrants carry a strike price of $1,000.00 per share, a 114.3% premium, designed to minimize potential equity dilution). The remainder for general corporate purposes, including investments to enhance supply chain capacity. More on Ciena Ciena: When The Beat Was Not Enough Why Ciena Fell By Nearly 20% After Posting Second Quarter Results Ciena C...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
A federal judge struck down a $100,000 fee President Donald Trump ordered for H-1B visa applications, providing a reprieve for US technology companies that rely on hiring skilled foreign workers. Bloomberg's Sankalp Phartiyal breaks down the developments. (Source: Bloomberg)
A federal judge struck down a $100,000 fee President Donald Trump ordered for H-1B visa applications, providing a reprieve for US technology companies that rely on hiring skilled foreign workers. Bloomberg's Sankalp Phartiyal breaks down the developments. (Source: Bloomberg)
(RTTNews) - Southwest Airlines Co. (LUV) announced late Monday its interline partnership with Singapore Airlines Ltd. (C6L.SI) to offer worldwide travelers single-ticket journeys to and from the United States.
(RTTNews) - Southwest Airlines Co. (LUV) announced late Monday its interline partnership with Singapore Airlines Ltd. (C6L.SI) to offer worldwide travelers single-ticket journeys to and from the United States.
Investors may need to rethink the most basic principles of portfolio management as artificial intelligence, geopolitical tensions and other structural shifts reshape markets, according to the BlackRock Investment Institute. The asset manager argued that traditional portfolio construction methods are becoming less effective in an investment environment increasingly driven by what it calls "mega for...
Investors may need to rethink the most basic principles of portfolio management as artificial intelligence, geopolitical tensions and other structural shifts reshape markets, according to the BlackRock Investment Institute. The asset manager argued that traditional portfolio construction methods are becoming less effective in an investment environment increasingly driven by what it calls "mega forces" — long-term changes ranging from AI and demographic shifts to geopolitical fragmentation and the energy transition. "We think this means investors should revisit big portfolio calls more often and have an explicit plan B portfolio ready," BII strategists led by Jean Boivin said. Among its highest-conviction tactical calls, BlackRock remains bullish on assets tied to the AI boom. It favors infrastructure and equipment supporting the AI buildout, including semiconductors, power systems and data centers, arguing these areas stand to benefit regardless of which companies ultimately emerge as winners. The firm also maintains an overweight position on U.S. equities, citing resilient earnings growth and expectations that AI will continue to boost corporate profits. In emerging markets, BlackRock prefers countries that manufacture critical AI components as well as commodity exporters that could benefit from higher energy and raw-material prices. The asset manager also suggested investors look beyond where a company is listed when making investment decisions. Instead, it said, greater emphasis should be placed on understanding a company's business model and revenue drivers. "What matters more is what a company actually does and the drivers of its revenue, not the country where its stock happens to be listed," BlackRock said. On fixed income, the asset manager is steering investors away from long-duration government debt. It is underweight long-term U.S. Treasurys, noting that inflation risks and rising term premiums continue to put upward pressure on yields. It also remains und...